News Announcement

Vivanza Biosciences: Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026

Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June 2026 along with year-to-date figures for the period from 1st April 2026 to 30th June 2026 together with the Limited Review Report (Annexure -A). and Other Business of the Company as enclosed.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan